Literature DB >> 7526097

Heparin-induced thrombocytopenia and antithrombotic therapy.

D M Boon, J J Michiels, J Stibbe, H H van Vliet, M C Kappers-Klunne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7526097     DOI： 10.1016/s0140-6736(94)90781-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

2.  Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.

Authors:  Laura Elizabeth Happe; Eileen Marie Farrelly; Richard H Stanford; Matt William Sarnes
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

3.  Heparin-induced thrombocytopenia post-cardiovascular interventional therapy: a case report.

Authors:  Lishui Shen; Xiaohua Liu; Lian Chen; Xiaofei Gao; Yizhou Xu
Journal:  BMC Cardiovasc Disord       Date:  2022-08-03       Impact factor: 2.174
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.